Ami Organics Limited, established in 2004 and headquartered in Surat, India, is a significant player in the pharmaceutical intermediates industry. The company specializes in manufacturing key active pharmaceutical ingredient intermediates such as Dolutegravir and Trazodone. Over the years, it has expanded its operations, including incorporating a joint venture in the USA and increasing its warehouse capacity. Notably, in 2021, Ami Organics raised Rs 570 crore through an IPO and acquired units from Gujarat Organics Limited, enhancing its production capabilities.
In recent developments, Ami Organics established a wholly owned subsidiary, Ami Organics Electrolytes Private Limited, in 2023 and began a brownfield project at Ankleshwar with a Rs. 1900 million capex to set up a new advanced technology plant. The company also acquired a 55% stake in Baba Fine Chemicals and developed a cutting-edge plant in Ankleshwar dedicated to producing advanced pharmaceutical intermediates.
